{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:29:33Z","timestamp":1787668173278,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","award":["WO2015123561A2"],"award-info":[{"award-number":["WO2015123561A2"]}],"id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","award":["WO2021062169A1"],"award-info":[{"award-number":["WO2021062169A1"]}],"id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY015130"],"award-info":[{"award-number":["R01EY015130"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY026877"],"award-info":[{"award-number":["P30EY026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY014880"],"award-info":[{"award-number":["P30EY014880"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY017011"],"award-info":[{"award-number":["R01EY017011"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014597","name":"LAM Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajo.2026.05.030","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:33:11Z","timestamp":1779582791000},"page":"261-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Asymmetric Peripheral Retinal Vascular Extension in Anti-Vascular Endothelial Growth Factor\u2013Treated Type 1 Retinopathy of Prematurity: Disparity Between Nasal and Temporal Hemispheres"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1042-5223","authenticated-orcid":false,"given":"NEAL","family":"SHAH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-7909","authenticated-orcid":false,"given":"MELISSA","family":"CHANDLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LYDIA","family":"SAUER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7270-5670","authenticated-orcid":false,"given":"M. ELIZABETH","family":"HARTNETT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2026.05.030_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/17469899.2019.1596026","article-title":"A review of treatment for retinopathy of prematurity","volume":"14","author":"Hansen","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.030_bib0002","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40123-023-00744-7","article-title":"Laser versus anti-VEGF: a paradigm shift for treatment-warranted retinopathy of prematurity","volume":"12","author":"Hartnett","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.030_bib0003","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/pediatric16030069","article-title":"Preferred treatment patterns of retinopathy of prematurity: an international survey","volume":"16","author":"Wang","year":"2024","journal-title":"Pediatr Rep"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.030_bib0004","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1111\/aos.15753","article-title":"Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry\u2014an exemplary comparison between 2011 and 2021","volume":"102","author":"Winter","year":"2024","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.030_bib0005","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2022.07.009","article-title":"Practice patterns and outcomes of intravitreal anti-VEGF injection for retinopathy of prematurity: an international multicenter study","volume":"129","author":"Patel","year":"2022","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.030_bib0006","article-title":"Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity","volume":"8","author":"Jang","year":"2023","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.030_bib0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-vision-093022-021420","article-title":"Pathophysiology of retinopathy of prematurity","volume":"9","author":"Hartnett","year":"2023","journal-title":"Annu Rev Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.030_bib0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10633-009-9181-x","article-title":"The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50\/10 OIR model","volume":"120","author":"Hartnett","year":"2010","journal-title":"Doc Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.030_bib0009","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1167\/iovs.08-3256","article-title":"The role of supplemental oxygen and JAK\/STAT signaling in intravitreous neovascularization in a ROP rat model","volume":"50","author":"Byfield","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.030_bib0010","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1167\/iovs.18-25525","article-title":"Discovering mechanisms in the changing and diverse pathology of retinopathy of prematurity: the Weisenfeld award lecture","volume":"60","author":"Hartnett","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2026.05.030_bib0011","doi-asserted-by":"crossref","DOI":"10.1096\/fba.2025-00146","article-title":"Endothelial MEMO1 regulates angiogenic signaling in a model of retinopathy of prematurity","volume":"7","author":"Ramshekar","year":"2025","journal-title":"FASEB Bioadv"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.030_bib0012","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10456-018-9618-5","article-title":"Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy","volume":"21","author":"Simmons","year":"2018","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.030_bib0013","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41598-018-20278-4","article-title":"Targeted Knockdown of overexpressed VEGFA or VEGF164 in Muller cells maintains retinal function by triggering different signaling mechanisms","volume":"8","author":"Becker","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2026.05.030_bib0014","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ajpath.2013.12.023","article-title":"VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis","volume":"184","author":"Yang","year":"2014","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.030_bib0015","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1167\/iovs.13-13755","article-title":"Targeting Muller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity","volume":"55","author":"Jiang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.030_bib0016","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ajpath.2013.05.011","article-title":"Short hairpin RNA-mediated knockdown of VEGFA in Muller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity","volume":"183","author":"Wang","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajo.2026.05.030_bib0017","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ajo.2023.12.008","article-title":"Extending peripheral retinal vascularization in retinopathy of prematurity through regulation of VEGF signaling","volume":"260","author":"Sauer","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.030_bib0018","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajo.2026.05.030_bib0019","first-page":"233","article-title":"Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.030_bib0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood-2006-07-037952","article-title":"Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ajo.2026.05.030_bib0021","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006452","article-title":"VEGF-directed blood vessel patterning: from cells to organism","volume":"2","author":"Bautch","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.030_bib0022","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1167\/iovs.08-1780","article-title":"Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease","volume":"49","author":"Hartnett","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.030_bib0023","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00018-013-1277-5","article-title":"Neurovascular development and links to disease","volume":"70","author":"Ruhrberg","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.030_bib0024","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.devcel.2009.07.011","article-title":"Local guidance of emerging vessel sprouts requires soluble Flt-1","volume":"17","author":"Chappell","year":"2009","journal-title":"Dev Cell"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.030_bib0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaapos.2007.04.008","article-title":"A pilot study using \u201cROPtool\u201d to quantify plus disease in retinopathy of prematurity","volume":"11","author":"Wallace","year":"2007","journal-title":"J AAPOS"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.030_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2025.104659","article-title":"Factors influencing the timing of complete retinal vascularization in infants screened for retinopathy of prematurity","volume":"29","author":"Kuziel","year":"2025","journal-title":"J AAPOS"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.030_bib0027","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1167\/iovs.13-13744","article-title":"Natural involution of acute retinopathy of prematurity not requiring treatment: factors associated with the time course of involution","volume":"55","author":"Ni","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.05.030_bib0028","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajo.2025.02.040","article-title":"Retinal vascularization rate predicts retinopathy of prematurity and remains unaffected by low-dose bevacizumab treatment","volume":"275","author":"Chang","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.030_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-82445-0","article-title":"A comparation of three different anti-VEGF drugs in development of persistent avascular retina in premature children","volume":"14","author":"\u00dcnal","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.030_bib0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4274\/tjo.galenos.2022.76436","article-title":"Avascular peripheral retina in infants","volume":"53","author":"\u00d6zdek","year":"2023","journal-title":"Turk J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.030_bib0031","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/01.iae.0000244292.86627.1e","article-title":"Rethinking STOP-ROP: is it worthwhile trying to modulate excessive VEGF levels in prethreshold ROP eyes by systemic intervention? A review of the role of oxygen, light adaptation state, and anemia in prethreshold ROP","volume":"26","author":"Gaynon","year":"2006","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.030_bib0032","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41372-018-0177-9","article-title":"Prethreshold retinopathy of prematurity: VEGF inhibition without VEGF inhibitors","volume":"38","author":"Gaynon","year":"2018","journal-title":"J Perinatol"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.030_bib0033","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.ophtha.2013.07.051","article-title":"Length of day during early gestation as a predictor of risk for severe retinopathy of prematurity","volume":"120","author":"Yang","year":"2013","journal-title":"Ophthalmology"},{"issue":"7436","key":"10.1016\/j.ajo.2026.05.030_bib0034","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature11823","article-title":"A direct and melanopsin-dependent fetal light response regulates mouse eye development","volume":"494","author":"Rao","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.030_bib0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/02713683.2022.2119254","article-title":"Vitreous humor: composition, characteristics and implication on intravitreal drug delivery","volume":"48","author":"Mishra","year":"2023","journal-title":"Curr Eye Res"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.030_bib0036","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3174\/ajnr.A2543","article-title":"Diffusion changes in the vitreous humor of the eye during aging","volume":"32","author":"Meral","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.030_bib0037","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/02713683.2022.2033271","article-title":"The roles of vitreous biomechanics in ocular disease, biomolecule transport, and pharmacokinetics","volume":"48","author":"Luo","year":"2023","journal-title":"Curr Eye Res."},{"issue":"13","key":"10.1016\/j.ajo.2026.05.030_bib0038","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1167\/iovs.13-12496","article-title":"Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function","volume":"54","author":"Tremblay","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.030_bib0039","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaapos.2012.12.155","article-title":"Effects of oxygen on the development and severity of retinopathy of prematurity","volume":"17","author":"Hartnett","year":"2013","journal-title":"J AAPOS"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.030_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74600-0","article-title":"Prenatal intrauterine growth restriction and risk of retinopathy of prematurity","volume":"10","author":"Chu","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.030_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/medicina62010095","article-title":"Early nutritional patterns and metabolic biomarkers associated with ROP severity","volume":"62","author":"Bujoreanu Bezman","year":"2026","journal-title":"Medicina"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:09:58Z","timestamp":1786090198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426002710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"alternative-id":["S0002939426002710"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.030","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric Peripheral Retinal Vascular Extension in Anti-Vascular Endothelial Growth Factor\u2013Treated Type 1 Retinopathy of Prematurity: Disparity Between Nasal and Temporal Hemispheres","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}